West Family Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
West Family Investments's NVS Position: Q2 2026 in Review
West Family Investments reduced its Novartis (NVS) stake by 4.4% in Q2 2026, selling an estimated $40.8K and leaving 5,931 shares worth $930K. The position accounts for 0.27% of the portfolio, ranked #63.
West Family Investments first reported a position in NVS in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.75M in Q4 2025. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- West Family Investments held 5,931 shares of Novartis worth $930K as of Q2 2026.
- West Family Investments sold 272 Novartis shares in Q2 2026, an estimated $40.8K.
- Novartis made up 0.27% of West Family Investments's portfolio in Q2 2026, its #63 holding.
- West Family Investments first reported a position in Novartis in Q2 2021 and has held it in 19 quarters since.
- West Family Investments's Novartis position peaked at $1.75M in Q4 2025.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.